A Case-Control Study of the APELA Gene and Hypertensive Disorders of Pregnancy

Medicina (Kaunas). 2022 Apr 26;58(5):591. doi: 10.3390/medicina58050591.

Abstract

Hypertensive disorders of pregnancy (HDPs) are believed to comprise a group of multifactorial genetic diseases. Recently, it was reported that APELA-knockout mice exhibited HDP-like symptoms, including proteinuria and elevated blood pressure due to defective placental angiogenesis. The aim of the present study is to determine the associations between HDPs and single-nucleotide variants or haplotypes in the human APELA gene through a case-control study. The subjects were 196 pregnant women with HDPs and a control group of 254 women without HDPs. Six single-nucleotide variants (rs2068792, rs13120303, rs4541465, rs13152225, rs78639146, and rs67448487) were selected from the APELA gene region. Although there were no significant differences for each single-nucleotide polymorphism in the case-control study, the frequency of the T-A haplotypes rs4541465-rs67448487 was significantly higher in the HDP group, especially in those with gestational hypertension, than in the control group. The results suggest that the APELA gene may be a disease-susceptibility gene for HDP.

Keywords: APELA; case-control study; haplotype; hypertensive disorders of pregnancy; variant.

MeSH terms

  • Animals
  • Case-Control Studies
  • Female
  • Humans
  • Hypertension, Pregnancy-Induced* / genetics
  • Mice
  • Peptide Hormones* / genetics
  • Placenta
  • Polymorphism, Single Nucleotide
  • Pregnancy

Substances

  • APELA protein, human
  • Peptide Hormones